Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial

Elisa Gremese, Florenzo Iannone, Giovanni La Montagna, Gianfilippo Bagnato, Annarita Giardina, Giovanni Lapadula

Risultato della ricerca: Contributo in rivistaArticolo in rivista

36 Citazioni (Scopus)

Abstract

To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.
Lingua originaleEnglish
pagine (da-a)286-292
Numero di pagine7
RivistaTHE JOURNAL OF RHEUMATOLOGY
Volume41
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Adult
  • Aged
  • Alanine Transaminase
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Aspartate Aminotransferases
  • DISEASE ACTIVITY SCORE
  • Drug Therapy, Combination
  • Female
  • GISEA
  • HEALTH ASSESSMENT QUESTIONNAIRE
  • Hepacivirus
  • Hepatitis C
  • Humans
  • Immunoglobulin G
  • Liver Function Tests
  • Male
  • Methotrexate
  • Middle Aged
  • Prospective Studies
  • Receptors, Tumor Necrosis Factor
  • Severity of Illness Index
  • TNF-α INHIBITORS
  • TRANSAMINASES
  • Treatment Outcome
  • Viral Load
  • Virus Replication

Fingerprint

Entra nei temi di ricerca di 'Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial'. Insieme formano una fingerprint unica.

Cita questo